Skip to main content
Log in

Expression of telomerase gene and apoptosis related genes in benign and malignant breast lesion

  • Published:
The Chinese-German Journal of Clinical Oncology

Abstract

Objective

To analyse the expression of telomerase and apoptosis related protein, and explore the possible mechanism of breast cancer development.

Methods

Immunohistochemistry method (SP) was used to detect the expression of hTERT, p53 and bcl-2 in the tissues of 48 cases of human breast cancer and 42 cases of benign lesions in breast.

Results

The positive rates of expression of hTERT, p53 and bcl-2 in breast cancer were 87.50%, 56.25% and 54.17%, respectively. Compared with the groups of adjacent noncancerous and benign lesions, there was a significant difference among three types of tissues (P < 0.05). The positive rates of expression of p53 and bcl-2 in the group with positive expression of hTERT were 64.28% and 61.90%, respectively, and their difference was significant compared with the negative group (P < 0.05).

Conclusion

There is a correlation between the activation of telomerases and p53 gene mutation in the development of breast cancer, and they are perhaps relation to the down regulation of bcl-2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Li H, Liu JP. Signaling on telomerase: a master switch in cell aging and immortalization. Biogerontology, 2002, 3: 107–116.

    Article  PubMed  CAS  Google Scholar 

  2. Harrington L, McPhail T, Mar V, et al. A mammalian telomerase-associated protein. Science, 1997, 275: 973–977.

    Article  PubMed  CAS  Google Scholar 

  3. Blackburn EH. Telomeres and telomerase. Keio J Med, 2000, 49: 59–65.

    PubMed  CAS  Google Scholar 

  4. Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer. Cancer Res, 1995, 55: 3259–3262.

    Google Scholar 

  5. Takakura M, Kyo S, Kanaya T, et al. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res, 1998, 58: 1558–1561.

    PubMed  CAS  Google Scholar 

  6. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science, 1995, 269: 1236–1241.

    Article  PubMed  CAS  Google Scholar 

  7. Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 1997, 90: 785–795.

    Article  PubMed  CAS  Google Scholar 

  8. Zhang ZW, Patchett SE, Farthing MJ. Role of Helicobacter pylori and p53 in regulation of epithelial cell cycle phase progression. Dig Dis Sci, 2002, 47: 987–985.

    Article  PubMed  CAS  Google Scholar 

  9. GAO G, Zhou CY, Lin ZY. The relationship between the gastric cancer and the Helicobacter pylori infection and the expression of c-myc, p53 gene. World J Gastroenterol (Chinese), 2000, 8: 941–943.

    Google Scholar 

  10. Harris AL. Mutation p53-the commonest genetic abnormality in human cancer. J Pathol, 1990, 162: 5–6.

    Article  PubMed  CAS  Google Scholar 

  11. Bonnefoy-Berard N, Aouacheria A, Verscheldee C, et al. Control of proliferation by Bcl-2 family members. Biochim Biophys Acta, 2004, 1644: 159–168.

    Article  PubMed  CAS  Google Scholar 

  12. Bosari S, Moneghini L, Graziani D, et al. bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinoma. Hum Pathol, 1995, 26: 534–540.

    Article  PubMed  CAS  Google Scholar 

  13. Wang XW, Guo XG, Bao L, et al. The expression of apoptosis regulation genes Bcl-2 and bad in benign and malignant breast tissues. Chin J Clin Oncol (Chinese), 2005, 32: 564–567.

    CAS  Google Scholar 

  14. Kusumoto M, Ogawa T, Mizumoto K, et al. Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells. Clin Cancer Res, 1999, 5: 2140–2147.

    PubMed  CAS  Google Scholar 

  15. Haldar S, Negrini M, Monne M, et al. Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res, 1994, 54: 2095–2097.

    PubMed  CAS  Google Scholar 

  16. Tsutsui S, Yasuda K, Suzuki K, et al. Bcl-2 protein expression is associated with p27 and p53 protein expression and MIB-1 counts in breast cancer. BMC Cancer, 2006, 6: 187.

    Article  PubMed  Google Scholar 

  17. Yang HY, Sun YT, Liu FS, et al. Expression of bcl-2 gene in relation to histologic type and grade. Chin J Oncol (Chinese), 2000, 22: 490–492.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mengquan Li.

Additional information

Supported by a grant from the Foundation of Health Department of Henan Province (No.20060038).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, M., Li, J., Su, J. et al. Expression of telomerase gene and apoptosis related genes in benign and malignant breast lesion. Chinese German J Clin Oncol 6, 361–364 (2007). https://doi.org/10.1007/s10330-007-0056-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10330-007-0056-x

Key words

Navigation